Endo Announces $200 Million Settlement for TRT Lawsuits
Endo Announces $200 Million Settlement for TRT Lawsuits
Introduction
Endo International announced a $200 million settlement, thus resolving 1,300 Testosterone product liability cases. The company stated this "master settlement agreement" will conclude "all known" cases and the deal does not include any admission of wrongdoing. The plaintiffs are required to release their claims from a settlement fund where the amount will be deposited by the company.
About 900 testosterone lawsuits are federally-filed against Endo and several other drugmakers for hiding potential risks of TRT. Additional lawsuits are also filed in the Philadelphia Court of Common Pleas and in state courts.
Testosterone Replacement therapy lawsuits were consolidated as a multidistrict litigation (MDL No. 2545 ) in June 2014 before U.S. District Judge Matthew Kennelly in the U.S. District Court for the Northern District of Illinois. All the lawsuits claim similar allegations that the drugmakers falsely marketed the TRT drug and failed to provide adequate warnings to the consumers.
Comments
Latest News
Study Links Roundup Chemical to Long-Term Brain Damage
Categories: Roundup
A recent study suggests that exposure to the widely used herbicide Roundup, which contains the active ingredient glyphosate, may be…
Zimmer Biomet Gets FDA Approval for Cementless Partial Knee
Categories: Zimmer Hip/Knee Replacement
Zimmer Biomet announced it has received supplemental FDA premarket approval (PMA) for the Oxford Cementless Partial…
Court Names Special Masters for Bard Mesh Claim Settlements
Categories: Hernia Mesh
The U.S. District Judge overseeing the federal litigation involving Bard hernia mesh lawsuits has appointed two…